ANIK
Anika Therapeutics, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
21.17
close · 2026-08-13
value
35
cheaper than peers35
quality
86
stronger fundamentals86
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 2.06× | 71 |
| price to sales | 2.35× | 60 |
| forward P/E | 22.28× | 20 |
| EV to EBITDA | 92.65× | 13 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 18.4% | 88 |
| revenue growth | 15.6% | 73 |
| operating margin | 11.4% | 60 |
| return on equity | -2.2% | 52 |
4 of 4 measures available
Facts
| market cap | $283M |
| free cash flow | $3.1M |
| employees | 235 |
| first trade | 1993-05-03 |
| next earnings | 2026-07-29 |
| fundamentals updated | 2026-08-13 |